Ticker >

Decipher Labs share price

Decipher Labs Ltd.

BSE: 524752 SECTOR: Pharmaceuticals & Drugs  19k   55   6

16.30
+0.21 (1.31%)
BSE: Today, 03:40 PM

Price Summary

Today's High

₹ 16.43

Today's Low

₹ 15.89

52 Week High

₹ 25.75

52 Week Low

₹ 14.5

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

16.46 Cr.

Enterprise Value

16.41 Cr.

No. of Shares

1.01 Cr.

P/E

0

P/B

1.87

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.71

CASH

0.06 Cr.

DEBT

0 Cr.

Promoter Holding

16.43 %

EPS (TTM)

₹  -0.47

Sales Growth

-18.05%

ROE

-25.63 %

ROCE

-25.84%

Profit Growth

-826.28 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-18.05%
3 Year-17.13%
5 Year-4.44%

Profit Growth

1 Year-826.28%
3 Year-349.76%
5 Year-270.36%

ROE%

1 Year-25.63%
3 Year-7.2%
5 Year-0.56%

ROCE %

1 Year-25.84%
3 Year-7.22%
5 Year-0.77%

Debt/Equity

0

Price to Cash Flow

-215.2

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 16.43 0
Dec 2023 16.43 0
Sep 2023 16.43 0
Jun 2023 16.43 0
Mar 2023 16.43 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 77.2358024691358 days.
  • Company has a healthy liquidity position with current ratio of 2.15339578454333.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 68.9135858740668.

 Limitations

  • The company has shown a poor profit growth of -349.761677643916% for the Past 3 years.
  • The company has shown a poor revenue growth of -17.1339447190311% for the Past 3 years.
  • Company has a poor ROE of -7.19525090894329% over the past 3 years.
  • Company has a poor ROCE of -7.21819875140828% over the past 3 years
  • Company has negative cash flow from operations of -0.0765.
  • The company has a low EBITDA margin of 1.85805777644708% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0.03 0.13 0 0 0.18
Total Expenditure 0.11 0.46 0.11 0.09 0.08
Operating Profit -0.08 -0.33 -0.11 -0.09 0.09
Other Income 0.01 0 0.01 0.01 0.01
Interest 0 0 0 0 0
Depreciation 0.02 0.01 0 0 0
Exceptional Items -2.24 0 0 0 0
Profit Before Tax -2.33 -0.34 -0.11 -0.09 0.09
Tax 0 0.03 0.02 -0.02 0
Profit After Tax -2.33 -0.37 -0.12 -0.08 0.09
Adjusted EPS (Rs) -2.31 -0.36 -0.12 -0.08 0.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 6.78 1.42 0.98 0.99 0.81
Total Expenditure 6.41 1.27 0.96 0.63 1.18
Operating Profit 0.37 0.16 0.02 0.36 -0.37
Other Income 0.01 0.01 0.14 0.05 0.03
Interest 0 0 0.02 0 0
Depreciation 0 0 0.04 0.05 0.06
Exceptional Items 0 0 0 0 -2.24
Profit Before Tax 0.38 0.17 0.1 0.36 -2.64
Tax 0 0 0 0 -0.02
Net Profit 0.38 0.17 0.1 0.36 -2.62
Adjusted EPS (Rs.) 0.47 0.17 0.1 0.36 -2.59

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 8 10.1 10.1 10.1 10.1
Total Reserves -5.5 0.97 1.06 1.42 -1.2
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0 -0.02
Current liabilities 3.34 0.58 0.23 0.08 0.09
Total Liabilities 5.84 11.65 11.4 11.6 8.97
Assets
Net Block 0.01 0.11 0.26 0.33 0.12
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.05 8.41 8.41 8.66 8.66
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 5.78 3.13 2.73 2.6 0.18
Total Assets 5.84 11.65 11.4 11.6 8.97
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.38 0.17 0.1 0.36 -2.64
Adjustment 0 0 0 0.06 2.37
Changes in Assets & Liabilities -0.34 -0.18 0.18 0.13 0.19
Tax Paid 0 0 0 0 0
Operating Cash Flow 0.04 -0.01 0.27 0.55 -0.08
Investing Cash Flow -0.05 -0.07 -0.19 -0.38 0.09
Financing Cash Flow 0.01 0.09 -0.09 -0.14 0
Net Cash Flow -0.01 0.01 -0.01 0.03 0.01

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 16.43 16.43 16.43 16.43 16.43
ajjarapu janakiram 16.43 16.43 16.43 16.43 16.43
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 83.57 83.57 83.57 83.57 83.57
seshu srinivas akula 3.80 3.80 3.80 3.80 3.80
suriadoss elumalai - 1.42 1.42 1.42 1.42
sushant mohan lal 2.14 2.14 2.14 2.14 2.14
kirti jain 1.03 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Decipher Labs informs about loss of share certificate20 Feb 2024, 12:24PM Decipher Labs - Quaterly Results14 Feb 2024, 7:07PM Decipher Labs informs about trading window closure30 Dec 2023, 1:25PM Decipher Labs informs about book closure and cut-off date 8 Sep 2023, 4:45PM Decipher Labs informs about newspaper clippings16 Feb 2023, 12:35PM Decipher Labs informs about closure of trading window27 Dec 2022, 4:32PM Decipher Labs informs about disclosure16 Sep 2022, 3:30PM Decipher Labs - Quaterly Results16 May 2022, 9:53PM Decipher Labs - Quaterly Results16 May 2022, 9:53PM Decipher Labs informs about disclosure5 Apr 2022, 2:35PM Decipher Labs informs about disclosure17 Mar 2022, 5:23PM Decipher Labs informs about disclosure14 Mar 2022, 9:09AM Decipher Labs informs about compliance certificate5 Jan 2022, 1:18PM Decipher Labs informs about disclosures 31 Dec 2021, 11:30AM Decipher Labs informs about updates17 Dec 2021, 12:57PM Decipher Labs informs about disclosure16 Dec 2021, 9:31AM Decipher Labs informs about disclosure14 Dec 2021, 11:29AM Decipher Labs opens branch office in Indore1 Dec 2021, 3:08PM Decipher Labs informs about business updates1 Dec 2021, 2:40PM Decipher Labs looking to foray into AI, Virtual Reality and Augmented Reality Space1 Dec 2021, 2:05PM Decipher Labs informs about annual report3 Sep 2021, 4:08PM Decipher Labs gets approval for incorporation of subsidiary company1 Jan 2021, 12:28PM Decipher Labs considering business expansion of portfolio to cater to retail sales of medicines24 Dec 2020, 12:24PM Decipher Labs informs about compliance certificate12 Oct 2020, 2:13PM Decipher Labs informs about outcome of board meeting3 Sep 2020, 10:36AM Decipher Labs informs about compliance certificate3 Jul 2020, 3:14PM Decipher Labs informs about board meeting19 Jun 2020, 4:31PM

Decipher Labs Stock Price Analysis and Quick Research Report. Is Decipher Labs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Decipher Labs and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Decipher Labs cash from the operating activity was Rs -0.0765 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Decipher Labs has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Decipher Labs , the EPS growth was -826.345291479821 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Decipher Labs has OPM of -45.4567901234568 % which is a bad sign for profitability.
     
  • ROE: Decipher Labs have a poor ROE of -25.6291001664545 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Decipher Labs is Rs 16.3. One can use valuation calculators of ticker to know if Decipher Labs share price is undervalued or overvalued.
Last Updated on:
Brief about Decipher Labs
X